BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10685573)

  • 1. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
    Inagi K; Rodriquez AA; Ford CN; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
    Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
    Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
    Boutsen F; Cannito MP; Taylor M; Bender B
    J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia.
    Nash EA; Ludlow CL
    Laryngoscope; 1996 Apr; 106(4):484-9. PubMed ID: 8614226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
    Young N; Blitzer A
    Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.
    Kim JW; Park JH; Park KN; Lee SW
    ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.